98%
921
2 minutes
20
Aim And Objective: Flexible ureteroscopy (fURS) is a well-established modality for managing urolithiasis in patients with congenital renal anomalies such as horseshoe kidneys (HK), malrotated kidneys (MK), and pelvic ectopic kidneys (PEK). Still, these anatomical variants present unique challenges that complicate stone clearance and procedural planning. We aim to apply machine learning (ML) and explainable artificial intelligence (XAI) techniques to identify predictors of stone-free status (SFS) following fURS in patients with anomalous kidneys.
Methods: We retrospectively analysed adult patients with HK, MK, or EK who underwent fURS and laser lithotripsy for renal stones at a tertiary referral center. A ML model incorporating clinical and intraoperative variables was developed to predict SFS. SHAP (SHapley Additive exPlanations) values and decision tree analysis were used to interpret feature importance and model behaviour.
Results: A total of 569 cases were analysed between 2017 and 2021, with a female: male ratio of 3:1. Regarding anatomical anomalies, 50.62% had HSK, 22.67% had PEK and 26.71% had MK. Most of the patients presented with multiple (59.58%), small (76.80%) and soft stones (56.94%). MK showed the highest SFS rates, suggesting this is the most favourable anomaly for fURS. The presence of residual fragments at the end of the procedure was the strongest negative predictor of SFS, followed by longer operative time and older patient age. PEK exhibited the greatest heterogeneity in outcomes. SHAP analysis provided individualized and global insights into feature contributions.
Conclusion: Explainable AI offers a transparent and clinically meaningful approach to predicting SFS in patients with renal anomalies undergoing fURS. These insights can guide preoperative risk stratification and inform surgical strategy in a domain where standardised evidence is lacking.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12405343 | PMC |
http://dx.doi.org/10.1007/s00345-025-05904-x | DOI Listing |
Clin Kidney J
September 2025
Hypertension is a pervasive and progressive complication in chronic kidney disease (CKD) patients, affecting up to 90% of those in advanced stages or on dialysis. A particularly insidious aspect of this condition is nocturnal hypertension, characterized by high blood pressure (BP) during sleep and a blunted or absent nighttime BP dipping-phenomena associated with accelerated CKD progression and increased cardiovascular risk. Despite its strong prognostic significance, nocturnal hypertension remains underdiagnosed due to limited use of ambulatory BP monitoring.
View Article and Find Full Text PDFBMC Nephrol
September 2025
School of Computer Science and Technology, Guangxi University of Science and Technology, Liuzhou, China.
Pediatr Nephrol
September 2025
Division of Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India.
Background: Kidney involvement in pediatric sarcoidosis is rare and often underrecognized, leading to diagnostic delays and treatment challenges. We report six patients with renal sarcoidosis to highlight their diverse presentations and outcomes and challenges in management.
Methods: Medical records of patients diagnosed with renal sarcoidosis during 2020-24 were reviewed.
Eur Arch Otorhinolaryngol
September 2025
Department of Otorhinolaryngology, Head and Neck Surgery, Beijing Tong Ren Hospital, Capital Medical University, No.1 Dongjiaominxiang Street, Beijing, 100730, China.
Objective: Kimura disease (KD) is a rare, chronic inflammatory disorder that is typically located in the head and neck region. It is characterized by subcutaneous nodules, eosinophilia, and elevated IgE levels. Its unclear etiology and similarities to malignancies create diagnostic and therapeutic challenges.
View Article and Find Full Text PDFIntroduction: Continuous renal replacement therapy (CRRT) is often performed for critically ill patients in intensive care units (ICUs), but its optimal indication and settings have yet to be determined. Thus, we aimed to describe the current status of CRRT in Japan through a multicenter retrospective observational study.
Methods: Adult ICU patients receiving CRRT at 18 tertiary hospitals in Japan (up to 100 patients from each hospital over the past year) were retrospectively enrolled.